| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/21/2007 | US7259166 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators |
| 08/21/2007 | US7259158 Naphthaline derivatives as H3 inverse agonists |
| 08/21/2007 | US7258702 Yellow cationic dyes for dyeing of organic material |
| 08/21/2007 | CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 08/16/2007 | WO2007091525A1 Photosensitizer dye |
| 08/16/2007 | WO2007091391A1 Improved method for producing nitroguanidine derivative |
| 08/16/2007 | WO2007091140A1 Substituted phenylsulfamoyl compounds as ppar agonists |
| 08/16/2007 | WO2007090752A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/16/2007 | WO2007090748A1 Benzamide and heteroarene derivatives |
| 08/16/2007 | WO2007090461A1 Use of metal complex compounds as oxidation catalysts |
| 08/16/2007 | WO2007090434A1 Substituted aryl oximes |
| 08/16/2007 | WO2007046513A3 Benzoylurea compounds and use thereof |
| 08/16/2007 | WO2007041365B1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 08/16/2007 | WO2007019397A3 6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus |
| 08/16/2007 | WO2006084688A8 HIV protease inhibitors |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | US20070191611 Comprising reacting a thiazolidine 2,4 dione and an intermediate metabisulphite complex of 4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzaldehyde; for treatment of non-insulin dependent diabetes mellitus |
| 08/16/2007 | US20070191608 intermediates for p38 MAP kinase inhibitors; industrial scale; 3-cyano-6-oxo-2-thio-1,6-dihydropyridines or pyrimidine, 2,4-diones as starting reactants and 2-cyano-N-phenylthioacetamide; cyclization; diazotization of 3-amino-7H-thieno[2,3-b]pyridin-6-ones, halide displacement |
| 08/16/2007 | US20070191486 thiocolchicine dimers with thiocolchicine residues are liked through a linear aliphatic amido or amido-ureido bridge; antiproliferative, antiinflammatory, antiarthritic, antiviral; enhanced cytotoxicity; 3,5-Benzenedicarboxylic acid bis-(N-deacetylthiocolchicine) amide |
| 08/16/2007 | US20070191437 Continuous Dosing Regimen |
| 08/16/2007 | US20070191436 Reduction of a keto ester of rosuvastatin in an organic solvent, hydrolysis; chemical intermediates |
| 08/16/2007 | US20070191420 Kinase inhibitors |
| 08/16/2007 | US20070191363 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues |
| 08/16/2007 | US20070191358 Novel piperidine derivative for the treatment of depression |
| 08/16/2007 | US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds |
| 08/16/2007 | US20070190325 Microcapsules with uv filter activity and process for producing them |
| 08/16/2007 | US20070190134 Compositions containing nicorandil, preparation method and use |
| 08/16/2007 | US20070187649 For inhibiting polymerization of ethylenically unsaturated monomers; includes a water-soluble phenylenediamine composition |
| 08/16/2007 | CA2641307A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 08/16/2007 | CA2637771A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/16/2007 | CA2637768A1 Benzamide and heteroarene derivatives |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1818322A1 Pyrene compound and, utilizing the same, light emitting transistor device and electroluminescence device |
| 08/15/2007 | EP1817309A1 Acetamide compounds as fungicides |
| 08/15/2007 | EP1817303A2 Substituted pyridines with activity on syk kinase |
| 08/15/2007 | EP1817301A1 Potentiators of glutamate receptors |
| 08/15/2007 | EP1817300A1 Potentiators of glutamate receptors |
| 08/15/2007 | EP1817288A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 08/15/2007 | EP1817287A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 08/15/2007 | EP1817282A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 08/15/2007 | EP1817106A2 Methods for producing a hexadentate bimetallic complex |
| 08/15/2007 | EP1697305B1 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists |
| 08/15/2007 | EP1549642B1 6-methylpyridine derivative, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
| 08/15/2007 | EP1392653B1 A short synthesis of pyridine-based pharmaceutical intermediates with sulfur-containing groups at the 2- and 3-positions |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | CN1331863C Imide analog compounds and its preparation method |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN1331857C Fused-polycyclic compounds |
| 08/15/2007 | CN1331856C Polyhydroxy stilbenes compound preparation and uses as drugs for suppressing SARS |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018774A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 08/15/2007 | CN101016309A Cadmium anthracene-9,10-dicarboxylate and 2,2-bipyridyl hybrid complex, preparing method and application thereof |
| 08/15/2007 | CN101016262A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative |
| 08/14/2007 | US7257287 Optical interleaver |
| 08/14/2007 | US7256289 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol |
| 08/14/2007 | US7256219 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2007 | US7256213 Taxanes having a C10 carbonate substituent |
| 08/14/2007 | US7256206 1-[4-(3-Amino-4-hydroxy-3-hydroxymethyl-butyl)-phenyl]-ethanone-O-biphenyl-4-ylmethyl-oxime, used as modulators of lipid activated G-protein coupled receptors specific for sphingosine-1-phosphate; prevention of autoimmune diseases or as angiogenesis inhibitors |
| 08/14/2007 | US7256204 6-(4-biphenylyl)methoxy-2-(2-(N,N-dimethylamino)ethyl)tetralin for example; inhibiting amyloid-beta protein production; for neurodegenerative diseases such as Alzheimer's disease |
| 08/14/2007 | US7256193 Therapeutic agents useful for treating pain |
| 08/14/2007 | CA2377217C Compound with tetrahydronaphthalene skeleton and liquid crystal composition containing the same |
| 08/14/2007 | CA2213714C Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/14/2007 | CA2206758C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/14/2007 | CA2193398C Benzocycloalkene compounds, their production and use |
| 08/09/2007 | WO2007089669A2 Processes for the preparation of compounds which modulate cell proliferation |
| 08/09/2007 | WO2007089455A1 Fluoroalkenyl derivatives as insecticides and nematicides |
| 08/09/2007 | WO2007089044A1 Process for production of aromatic compound |
| 08/09/2007 | WO2007088876A1 Pyridone derivative and herbicide |
| 08/09/2007 | US20070185331 In-situ treatment of pyridine 2,3-dicarboxylic acid esters with an oxidizing agent |
| 08/09/2007 | US20070185171 Compounds and methods of use |
| 08/09/2007 | US20070185170 1,1'-(benzene-1,3-diylmethylene)bis[4-(4-chloro-N-methylanilino)pyridinium]dibromide, that inhibit phosphorylcholine biosynthesis by selective blocking of the choline kinase enzyme in tumor cells or in cells affected by parasitic infections; anticarcinogenic or antitumor agents; fungicides; viricides |
| 08/09/2007 | US20070185116 Bicyclic compounds |
| 08/09/2007 | US20070185109 Idene derivatives and process for the preparation thereof |
| 08/09/2007 | US20070185105 Calcium channel blockers |
| 08/09/2007 | US20070184537 Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides |
| 08/09/2007 | DE102006005103A1 Oxonium- und Sulfoniumsalze Oxonium and sulfonium salts |
| 08/09/2007 | CA2640049A1 Pyridylphenyl compounds for inflammation and immune-related uses |
| 08/08/2007 | EP1816124A2 Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy |
| 08/08/2007 | EP1815872A1 Composition for amyloid-associated disease diagnosis |
| 08/08/2007 | EP1814877A2 Diphenyl substituted alkanes as flap inhibitors |
| 08/08/2007 | EP1814856A1 Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes |
| 08/08/2007 | EP1814855A2 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 08/08/2007 | EP1814854A1 Cationic ceramides, and analogs thereof, and their use for preventing or treating cancer |
| 08/08/2007 | EP1814853A2 Hydroxybenzoate salts of metanicotine compounds |
| 08/08/2007 | EP1814852A2 Hydroxybenzoate salts of metanicotine compounds |
| 08/08/2007 | EP1814850A1 New histone deacetylases inhibitors |
| 08/08/2007 | EP1814841A2 Ceramides and apoptosis-signaling ligand |
| 08/08/2007 | EP1740543B1 Vapor phase catalytic chlorination of beta-picoline |
| 08/08/2007 | EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 08/08/2007 | EP1631285B1 Therapeutic agents useful for treating pain |
| 08/08/2007 | EP1532111B1 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/08/2007 | EP1349962A4 Methods and compositions for detecting polynucleotide duplex damage |
| 08/08/2007 | EP1343530B1 Oral pharmaceutical composition containing a block copolymer |
| 08/08/2007 | EP1095037B2 process of synthesis of 5-methoxy- 2- (4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl|sulfinyl-1h-benzimidazole |
| 08/08/2007 | EP1039804A4 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
| 08/08/2007 | EP0767912B1 Luminescent lanthanide chelates and methods of use |
| 08/08/2007 | CN1330644C Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 08/08/2007 | CN1330636C Synthesis process of Tilofiban hydrochloride intermediate |
| 08/08/2007 | CN1330634C Antibacterial agents |